Expert second opinions for coronary graft failure. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Coronary Graft Failure can develop narrowing or complete occlusion over time. If you are facing a decision about coronary graft failure, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Coronary bypass grafts can develop narrowing or complete occlusion over time. Saphenous vein grafts have 10-year patency rates of approximately 50-60%, while internal mammary artery grafts maintain patency above 90% at 10 years. Graft failure can cause recurrent angina or acute coronary syndrome.
The management of graft failure is complex, involving choices between PCI (stenting) of native vessels or grafts, redo CABG, or maximized medical therapy. Redo CABG carries higher risk but may provide more complete revascularization. The optimal strategy depends on graft anatomy, native vessel disease, and patient risk factors.
Surgery for coronary graft failure depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. The management of graft failure is complex, involving choices between PCI (stenting) of native vessels or grafts, redo CABG, or maximized medical therapy. Redo CABG carries higher risk but may provide more complete revascularization. The optimal strategy depends on graft anatomy, native vessel disease, and patient risk factors.
Operative mortality for coronary graft failure-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for coronary graft failure depends on anatomy, comorbidities, age, and personal goals. PCI vs redo CABG for graft failure. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.